
AssayQuant’s mission is to support the development of more effective therapies for cancer, chronic inflammation, neurodegeneration, and other serious conditions. Our team is motivated by a shared vision of reducing suffering, to build a healthier world. AssayQuant's Proprietary PhosphoSens® Technology uses novel, fluorogenic sensors in enzyme recognition sequences that are carefully optimized for each enzyme to relay quantitative information on phosphorylation in real time with less effort. Our direct, real-time, kinetic, enzyme activity assays yield better, more reliable data than other methods, enabling better decisions regarding target biology and generation of lead candidates to empower faster movement through the drug discovery process. Whether used in high, moderate or low throughput modes, the resulting richer information from quantitative data allows you to rapidly rank candidates by inhibition mechanism, selectivity profiling and multiple measures of potency, with covalent and reversible inhibitors and fragments. AssayQuant has a catalog of over four hundred optimized assays, developed from curated libraries of tens of thousands of fluorogenic peptide sensor substrates, and also provides services to develop novel optimized assays for you. Why not use the best substrate for your assays, designed for your enzyme?
AssayQuant Technologies Inc.
260 Cedar Hill Street
Marlboro, MA 01752